Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
British Journal of Anaesthesia|September 15, 2022
Postoperative recovery with continuous erector spinae plane block or video-assisted paravertebral block after minimally invasive thoracic surgery: a prospective, randomised controlled trialAneurin Moorthy, Aisling Ní Eochagáin, Eamon Dempsey, et al.
British Journal of Anaesthesia|July 4, 2020
Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trialElena V Galoș, Tiberiu-Florin Tat, Răzvan Popa, et al.
Frontiers in Oncology|April 1, 2022
Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression ProjectAmparo Belltall, Sheila Zúñiga-Trejos, Iris Garrido-Cano, et al.
Blood|January 27, 2012
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemiaMartin F M de Rooij, Annemieke Kuil, Christian R Geest, et al.
Molecular Cancer Therapeutics|May 30, 2006
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivoJoseph J Buggy, Z Alexander Cao, Kathryn E Bass, et al.
Annals of Hematology|September 3, 2014
Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinibDavid D Smith, Leanne Goldstein, Mei Cheng, et al.
Leukemia|November 26, 2013
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activityS Cheng, J Ma, A Guo, et al.
BMJ Open|October 30, 2024
Assessing the relative efficacy of components of opioid-free anaesthesia in adult surgical patients: protocol for a systematic review and component network meta-analysisAmparo Belltall, Guido Mazzinari, Aisling Ní Eochagáin, et al.
Cancer Immunology Research|August 23, 2018
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical ModelsStephen B Willingham, Po Y Ho, Andrew Hotson, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Pageof 21